ABCB4 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

71 results for “ABCB4”

Trials

View all 41 →

ABCB4 Gene Mutations in Intrahepatic Cholestasis of Pregnancy and Controls

120 participants · First posted Jun 18, 2008

Genetic Polymorphisms of ABCB11 and ABCB4 in Women With Intrahepatic Cholestasis of Pregnancy (ICP) and in Their First Degree Relatives

50 participants · First posted Feb 24, 2020

ABCB1 SNPs as Predictors of PIPN

92 participants · First posted Oct 26, 2021

Drugs

View all 23 →

ABCB4 gene therapy (ModeRNA Therapeutics/Beth Israel Deaconess Medical Center)

ABCB4 gene therapy (lipid nanoparticles, progressive familial intrahepatic cholestasis type 3)

ABCG4 inhibitiors

News

Rectify Pharmaceuticals Unveils RTY-406, an Oral Dual ABCB4/BSEP Modulator for Primary Sclerosing Cholangitis

Rectify Pharmaceuticals Reports Promising Preclinical Data for RTY-406 in Primary Sclerosing Cholangitis at EASL 2026

Rectify Pharma's Novel Dual-Targeted PFM Shows Promise for Hepatobiliary Diseases at EASL 2025

Page 1 of 8